[Efficacy and safety of ruxolitinib in the salvage treatment of chronic graft versus-host disease].
Zhonghua Yi Xue Za Zhi
; 100(16): 1235-1239, 2020 Apr 28.
Article
in Zh
| MEDLINE
| ID: mdl-32344495
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Observational_studies
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Yi Xue Za Zhi
Year:
2020
Document type:
Article
Affiliation country:
China
Country of publication:
China